BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15981802)

  • 1. Classifying "recurrent" breast cancer: lost heterozygosity found.
    Hameed O; Pfeifer JD
    Am J Clin Pathol; 2005 May; 123(5):641-3. PubMed ID: 15981802
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors.
    Goldstein NS; Vicini FA; Hunter S; Odish E; Forbes S; Kraus D; Kestin LL
    Am J Clin Pathol; 2005 May; 123(5):679-89. PubMed ID: 15981807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral leukoplakia in a patient with Fanconi anemia: recurrence or a new primary lesion?
    Resende RG; Correia-Silva Jde F; Galvão CF; Gomes CC; Carneiro MA; Gomez RS
    J Oral Maxillofac Surg; 2011 Jul; 69(7):1940-3. PubMed ID: 21549482
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrative tumor board: recurrent breast cancer or new primary? Integrative physician's perspective.
    Block KI
    Integr Cancer Ther; 2003 Sep; 2(3):301-5. PubMed ID: 15035895
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrative tumor board: recurrent breast cancer or new primary? Medical oncology.
    Boyd DB
    Integr Cancer Ther; 2003 Sep; 2(3):270-2. PubMed ID: 15035890
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
    Schmaltz J
    Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889
    [No Abstract]   [Full Text] [Related]  

  • 7. Postexcisional recurrence of carcinoma of the breast.
    Zavotsky J; Gardner B
    J Am Coll Surg; 1996 Jan; 182(1):71-7. PubMed ID: 8542095
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrative tumor board: recurrent breast cancer or new primary? UCSF Osher Center for Integrative Medicine and UCSF Carol Franc Buck Breast Care Center.
    Jacobs BP; Burns B; Marya R; Chapman J; Stone B; Hwang S; Goldman M; Barrows K; Hamolsky D; Sampel K
    Integr Cancer Ther; 2003 Sep; 2(3):289-300. PubMed ID: 15035894
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrative tumor board: recurrent breast cancer or new primary? Naturopathic medicine.
    Fulop JA
    Integr Cancer Ther; 2003 Sep; 2(3):276-83. PubMed ID: 15035892
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrative tumor board: recurrent breast cancer or new primary? Mind-body-spirit medicine.
    Mehl-Madrona L
    Integr Cancer Ther; 2003 Sep; 2(3):283-9. PubMed ID: 15035893
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Antonucci JV; Goldstein N; Wallace M; Kestin L; Krauss D; Kunzmann J; Gilbert S; Schell S
    Cancer; 2007 Apr; 109(7):1264-72. PubMed ID: 17372920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiosarcoma at the anastomotic site mimicking local recurrence of rectal adenocarcinoma.
    Jahn SW; Liegl B; Leskowschek H; Spreizer C; Langner C
    Endoscopy; 2011; 43 Suppl 2 UCTN():E293-4. PubMed ID: 21915833
    [No Abstract]   [Full Text] [Related]  

  • 13. [After care of breast carcinoma patients--recommendations from the Berlin consensus conference].
    Hellriegel KP; Schulz KD
    Fortschr Med; 1996 Feb; 114(5):43-5. PubMed ID: 8867474
    [No Abstract]   [Full Text] [Related]  

  • 14. Microsatellite analyses of recurrence or second primary tumor in head and neck cancer.
    Ronchetti D; Arisi E; Neri A; Pruneri G; Digiuni B; Sambataro G; Gallo O; Pignataro L
    Anticancer Res; 2005; 25(4):2771-5. PubMed ID: 16080525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up care of patients with breast cancer.
    Tolaney SM; Winer EP
    Breast; 2007 Dec; 16 Suppl 2():S45-50. PubMed ID: 17697780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of recurrent breast cancer for which NSE was a useful tumor marker].
    Takise A; Takagi H; Abe T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):79-83. PubMed ID: 3379335
    [No Abstract]   [Full Text] [Related]  

  • 17. Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcome.
    Courdi A; Largillier R; Ferrero JM; Lallement M; Raoust I; Ettore F; Peyrottes I; Chamorey E; Balu-Maestro C; Chapellier C
    Oncology; 2006; 71(5-6):361-8. PubMed ID: 17785993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinoma masquerading as recurrent primary breast lymphoma.
    Raman SR; Patel B; Haji A; Bates T
    Int J Clin Pract; 2008 Jun; 62(6):968-9. PubMed ID: 17868347
    [No Abstract]   [Full Text] [Related]  

  • 19. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.
    Bollet MA; Servant N; Neuvial P; Decraene C; Lebigot I; Meyniel JP; De Rycke Y; Savignoni A; Rigaill G; Hupé P; Fourquet A; Sigal-Zafrani B; Barillot E; Thiery JP
    J Natl Cancer Inst; 2008 Jan; 100(1):48-58. PubMed ID: 18159071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced extraskeletal fibrosarcoma: simulating locally recurrent carcinoma of breast.
    Friedman IH; Mori K; Kabakow B
    N Y State J Med; 1977 Oct; 77(12):1932-5. PubMed ID: 199864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.